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Although an array of myosin heads can be visualised in the presence of FEDA-ATP by fluorescence microscopy, only low concentrations (50 nM) of the latter can be used, so as to minimise the background signal from the free fluorophore. Total internal reflectance fluorescence microscopy offers one possibility around this problem [2] . An alternative strategy is to cage the fluorescein [ 31 to make a non-fluorescent derivative which can be photoactivated in localised regions containing the array of myosin heads. Any free fluorophores activated in this process are expected to diffuse from the site of interest within several milliseconds.
We have prepared a non-fluorescent biscaged derivative of FEDA-ATP by reacting the succinimidyl ester of carboxyfluorescein-bis-(4,5dimethoxy-2-ni~benzyl) ether (Molecular Probes Inc., Oregon, U.S.A.)) with the 2', (3') ethylenediamine derivative of ATP (Fig. 1) . The latter (EDA-ATP) was prepared as described previously [ 11. Such a caged FEDA-ATP is a substrate for rabbit skeletal myosin subfragment 1. Fig. 1 The structure of caged FEDA-ATP succinimidyl ester rather than isothiocyanate to link to the amine of EDA-ATP, a ureido rather that thioureido group is present in the photoactivated product). The irradiated preparation shows a quench in fluorescein emission on binding to myosin subfragment 1, followed by a recovery corresponding to the product release phase. This is similar to FEDA-ATP itself [l].
As a preliminary to the photoactivation of caged FEDA-ATP when bound to myosin molecular arrays, it is desirable to produce a long-lived myosin products complex to allow optimisation of the microbeam optics. We have therefore explored the formation of the M.FEDA-ADP.AlF4-complex using AlF4-as a phosphate analogue [4] . Addition indicative of a myosin products complex formation. At the concentrations used the half time for the reaction was 115 mh, corresponding to a pseudo fmt order association rate constant of 1 x 104 s-1. When the fluorescence change was complete, an excess of ATP was added and the recovery of fluorescence was monitored after an overnight incubation. These studies suggested that the dissociation of FEDA-ADP from the complex was less than 6 x 10-6 s-1. The aluminium fluoride complex therefore provides a convenient way of trapping fluorescent ATP derivatives at the myosin active site. Previous attempts using vanadate as a phosphate analogue were thwarted by excessive quenching of the fluorescence signal.
We are now developing ways of producing a p n diameter photolysis beam in the microscope for local activation. Projection of an illuminated slit through the epifluorescence port is a possible arrangement [3] , but the relatively low numerical aperture of the latter leads to a loss of light intensity which is not desirable when using a Xe flash lamp. Direct laser illumination may offer a more flexible approach. With this accomplished, it should be possible to selectively illuminate a track of myosin heads during an in v i m motility assay driven by caged FEDA-ATP hydrolysis. Fluorescent FEDA-ATP produced at the myosin active site will be displaced by non-photolysed caged FEDA-ATP from the surrounding medium with kinetics controlled by the turnover rate of the former, and thus provide a direct measure of the ATPase under the assay conditions.
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